GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.10% | 33.88% | -25.62% | -15.49% | 43.38% |
| Total Depreciation and Amortization | -34.17% | -35.87% | -68.35% | -70.90% | -68.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 224.22% | 215.76% | 111.57% | 110.63% | -81.42% |
| Change in Net Operating Assets | -311.92% | -306.38% | 669.90% | 623.93% | -18.81% |
| Cash from Operations | -31.06% | -27.62% | 64.70% | 67.55% | 34.51% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5,007.41% | 5,029.63% | -530.00% | -492.96% | -92.39% |
| Cash from Investing | 4,922.22% | 4,944.44% | -563.08% | -529.23% | -91.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 63.83% | 63.83% | 13.02% | 13.02% | -754.98% |
| Issuance of Common Stock | 8.61% | 8.61% | -93.29% | -93.29% | 33.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | 94.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 464.16% | 464.16% | -103.33% | -103.33% | -1,171.59% |
| Cash from Financing | 569.52% | 551.98% | -97.30% | -97.52% | -85.26% |
| Foreign Exchange rate Adjustments | 98.93% | 98.90% | 104.55% | 90.91% | -573.95% |
| Miscellaneous Cash Flow Adjustments | 20.00% | 0.00% | -- | -- | 200.00% |
| Net Change in Cash | 152.36% | 150.99% | -148.14% | -144.25% | -498.20% |